![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Kinnate Biopharma Inc | NASDAQ:KNTE | NASDAQ | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 2.65 | 2.64 | 2.65 | 0 | 01:00:00 |
|
|
|
(State or other jurisdiction of incorporation)
|
(Commission File Number)
|
(IRS Employer Identification No.)
|
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
Title of each class
|
Trading
Symbol(s)
|
Name of each exchange
on which registered
|
||
|
|
|
Item 7.01 |
Regulation FD Disclosure.
|
Item 9.01 |
Financial Statements and Exhibits.
|
Exhibit No.
|
Description
|
104
|
Cover page interactive data file (embedded within the inline XBRL document).
|
KINNATE BIOPHARMA INC.
|
||
Date: January 16, 2024
|
By:
|
/s/ Nima Farzan
|
|
Nima Farzan
|
|
Chief Executive Officer and President
|
Document and Entity Information |
Jan. 09, 2024 |
---|---|
Cover [Abstract] | |
Document Type | 8-K |
Amendment Flag | false |
Document Period End Date | Jan. 09, 2024 |
Entity File Number | 001-39743 |
Entity Registrant Name | KINNATE BIOPHARMA INC. |
Entity Central Index Key | 0001797768 |
Entity Incorporation, State or Country Code | DE |
Entity Tax Identification Number | 82-4566526 |
Entity Address, Address Line One | 103 Montgomery Street, Suite 150 |
Entity Address, Address Line Two | The Presidio of San Francisco |
Entity Address, City or Town | San Francisco |
Entity Address, State or Province | CA |
Entity Address, Postal Zip Code | 94129 |
City Area Code | 858 |
Local Phone Number | 299-4699 |
Title of 12(b) Security | Common Stock, par value $0.0001 per share |
Trading Symbol | KNTE |
Security Exchange Name | NASDAQ |
Entity Emerging Growth Company | true |
Entity Ex Transition Period | false |
Written Communications | false |
Soliciting Material | false |
Pre-commencement Tender Offer | false |
Pre-commencement Issuer Tender Offer | false |
1 Year Kinnate Biopharma Chart |
1 Month Kinnate Biopharma Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions